Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452

The Statistical Analysis of Failure Time Data.

Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875

Validation of a combined comorbidity index

Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587

International scoring system for evaluating prognosis in myelodysplastic syndromes

Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427

Regression modelling strategies for improved prognostic prediction

Harrell, F. E., Lee, K. L., Califf, R. M., Pryor, D. B., & Rosati, R. A. (1984) · Statistics in Medicine · doi:10.1002/sim.4780030207 · Cited by 1,804

Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives

Romano, P. S., Roos, L. L., & Jollis, J. G. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90103-8 · Cited by 1,717

The pre-therapeutic classification of co-morbidity in chronic disease

Feinstein, A. R. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90054-8 · Cited by 1,544

Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

Storb, R. F., Deeg, H. J., Whitehead, J., Appelbaum, F. R., Beatty, P. G., Bensinger, W., Buckner, C. D., Clift, R. A., Doney, K., Farewell, V. T., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141201 · Cited by 1,411

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

McSweeney, P. A., Niederwieser, D. W., Shizuru, J. A., Sandmaier, B. M., Molina, A. J., Maloney, D. G., Chauncey, T. R., Gooley, T. A., Hegenbart, U., Nash, R. A., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3390 · Cited by 1,386

The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation

Scott, B. L., Gooley, T. A., Sorror, M. L., Rezvani, A. R., Linenberger, M. L., Grim, J. A., Sandmaier, B. M., Myerson, D., Chauncey, T. R., Storb, R. F., et al. (2012) · Blood · doi:10.1182/blood-2011-08-372904 · Cited by 151

DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant

Dillon, L. W., Gui, G., Page, K. M., Ravindra, N., Wong, Z. C., Andrew, G. M., Mukherjee, D., Zeger, S. L., Chaer, F. E., Spellman, S. R., et al. (2023) · JAMA · doi:10.1001/jama.2023.1363 · Cited by 154

Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease

Saraf, S. L., Oh, A. L., Patel, P. R., Jalundhwala, Y. J., Sweiss, K. I., Koshy, M., Campbell‐Lee, S. A., Gowhari, M., Hassan, J., Peace, D. J., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.08.036 · Cited by 150

Haematopoietic stem cell transplants: principles and indications

Balassa, K., Danby, R., & Rocha, V. (2018) · British Journal of Hospital Medicine · doi:10.12968/hmed.2019.80.1.33 · Cited by 148

Hematopoietic stem cell transplantation

Hatzimichael, E. C., & Tuthill, M. H. (2010) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s6815 · Cited by 148

Acute myeloid leukemia in the older adults

Almeida, A. M., & Ramos, F. (2016) · Leukemia Research Reports · doi:10.1016/j.lrr.2016.06.001 · Cited by 147

Frontline treatment of acute myeloid leukemia in adults

Tamamyan, G., Kadia, T. M., Ravandi, F., Borthakur, G. M., Cortes, J. E., Jabbour, E. J., Daver, N. G., Ohanian, M. N., Kantarjian, H. M., & Konopleva, M. Y. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.12.004 · Cited by 151

Association of Comorbidities With Overall Survival in Myelodysplastic Syndrome: Development of a Prognostic Model

Naqvi, K., Garcia‐Manero, G., Sardesai, S. D., Oh, J. H., Vigil, C. E., Pierce, S. A., Lei, X. J., Shan, J., Kantarjian, H. M., & Suarez-Almazor, M. E. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.3353 · Cited by 145

Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation

Duléry, R., Mohty, R., Labopin, M., Sestili, S., Malard, F., Brissot, É., Battipaglia, G., Mediavilla, C., Banet, A., de Wyngaert, Z. V., et al. (2021) · JACC CardioOncology · doi:10.1016/j.jaccao.2021.02.011 · Cited by 145

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors

Shanavas, M., Popat, U., Michaelis, L. C., Fauble, V. D. S., McLornan, D. P., Klisovic, R. B., Mascarenhas, J. O., Tamari, R., Arcasoy, M. O., Davies, J. O. J., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.10.005 · Cited by 147

Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic Transplantation

Getta, B. M., Devlin, S. M., Levine, R. L., Arcila, M. E., Mohanty, A. S., Zehir, A., Tallman, M. S., Giralt, S. A., & Roshal, M. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.03.017 · Cited by 141

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.

Wierda, W. G., Byrd, J. C., Abramson, J. S., Bilgrami, S., Bociek, G., Brander, D. M., Brown, J. R., Chanan-Khan, A. A., Chávez, J. C., Coutre, S. E., et al. (2020) · PubMed · doi:10.6004/jnccn.2020.0006 · Cited by 142

History of hematopoietic cell transplantation: challenges and progress

Granot, N., & Storb, R. F. (2020) · Haematologica · doi:10.3324/haematol.2019.245688 · Cited by 138

The Feasibility of Inpatient Geriatric Assessment for Older Adults Receiving Induction Chemotherapy for Acute Myelogenous Leukemia

Klepin, H. D., Geiger, A. M., Tooze, J. A., Kritchevsky, S. B., Williamson, J. D., Ellis, L. R., Levitan, D. A., Pardee, T. S., Isom, S. P., & Powell, B. L. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03614.x · Cited by 140

The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial

Burnett, A. K., Milligan, D. W., Goldstone, A. H., Prentice, A. G., McMullin, M., Dennis, M. W., Sellwood, E., Pallis, M., Russell, N. H., Hills, R. K., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07604.x · Cited by 139

Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation

Tichelli, A., Bhatia, R., & Socié, G. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07165.x · Cited by 139

Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia

Malfuson, J. V., Etienne, A., Turlure, P., de Revel, T., Thomas, X., Contentin, N., Terré, C., Rigaudeau, S., Bordessoule, D., Vey, N., et al. (2008) · Haematologica · doi:10.3324/haematol.13309 · Cited by 138

Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantation

El‐Jawahri, A. R., Vandusen, H. B., Traeger, L. N., Fishbein, J. N., Keenan, T., Gallagher, E. R., Greer, J. A., Pirl, W. F., Jackson, V. A., Spitzer, T. R., et al. (2016) · Cancer · doi:10.1002/cncr.29818 · Cited by 137

Expanding the role of umbilical cord blood transplantation

Brunstein, C. G., Setubal, D. C., & Wagner, J. E. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06521.x · Cited by 137

Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease

Bachanová, V., Marks, D. I., Zhang, M.-J., Wang, H., Lima, M. J. G. D., Aljurf, M. D., Arellano, M. L., Artz, A. S., Bacher, U., Cahn, J.-Y. Y., et al. (2013) · Leukemia · doi:10.1038/leu.2013.253 · Cited by 135

Application of machine learning algorithms for clinical predictive modeling: a data-mining approach in SCT

Shouval, R., Bondi, O., Mishan‐Shamay, H., Shimoni, A., Unger, R., & Nagler, A. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2013.146 · Cited by 140

The Graft-Versus-Leukemia Effect in AML

Sweeney, C., & Vyas, P. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01217 · Cited by 144

Performance Status and Comorbidity Predict Transplant-Related Mortality After Allogeneic Hematopoietic Cell Transplantation

Artz, A. S., Pollyea, D. A., Kocherginsky, M., Stock, W., Rich, E. S., Odenike, O. M., Zimmerman, T. M., Smith, S. M., Godley, L. A., Thirman, M. J., et al. (2006) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.05.015 · Cited by 134

Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

Röllig, C., Krämer, M., Schliemann, C., Mikesch, J., Steffen, B., Krämer, A., Noppeney, R., Schäfer‐Eckart, K., Krause, S. W., Hänel, M., et al. (2020) · Blood · doi:10.1182/blood.2019004583 · Cited by 133

Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years

Cornelissen, J. J., Versluis, J., Passweg, J. R., van Putten, W. L. J., Manz, M. G., Maertens, J. A., Beverloo, H. B., Valk, P. J. M., Kooy, M. V. M., Wijermans, P., et al. (2014) · Leukemia · doi:10.1038/leu.2014.332 · Cited by 131

Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities

Eissa, H., Gooley, T. A., Sorror, M. L., Nguyen, F., Scott, B. L., Doney, K., Loeb, K. R., Martin, P. J., Pagel, J. M., Radich, J. P., et al. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.09.018 · Cited by 130

Pilot Study of Comprehensive Geriatric Assessment (CGA) in Allogeneic Transplant: CGA Captures a High Prevalence of Vulnerabilities in Older Transplant Recipients

Muffly, L. S., Boulukos, M., Swanson, K., Kocherginsky, M., del Cerro, P., Schroeder, L., Pape, L., Extermann, M., van Besien, K., & Artz, A. S. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2012.11.006 · Cited by 130

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission

Rashidi, A., Hamadani, M., Zhang, M., Wang, H.-L., Abdel‐Azim, H., Aljurf, M. D., Assal, A., Bajel, A. R., Bashey, A., Battiwalla, M., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000050 · Cited by 130

Influence of Pretransplantation Serum Ferritin on Nonrelapse Mortality after Myeloablative and Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation

Kataoka, K., Nannya, Y., Hangaishi, A., Imai, Y., Chiba, S., Takahashi, T., & Kurokawa, M. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.11.012 · Cited by 129

Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial

Choi, S. W., Braun, T., Chang, L., Ferrara, J. L. M., Pawarode, A., Magenau, J. M., Hou, G., Beumer, J. H., Levine, J. E., Goldstein, S., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70512-6 · Cited by 130

Milestones of Hematopoietic Stem Cell Transplantation – From First Human Studies to Current Developments

Juric, M. K., Ghimire, S., Ogonek, J., Weissinger, E. M., Holler, E., van Rood, J. J., Oudshoorn, M., Dickinson, A. M., & Greinix, H. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00470 · Cited by 138

Red Blood Cell Transfusion Dependence and Outcome after Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with de Novo Myelodysplastic Syndrome (MDS)

Platzbecker, U., Bornhäuser, M., Germing, U., Stumpf, J., Scott, B. L., Kröger, N. M., Schwerdtfeger, R., Böhm, A., Kobbe, G., Theuser, C., et al. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.08.006 · Cited by 126

Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents

Barrett, A. J., & Savani, B. N. (2006) · Leukemia · doi:10.1038/sj.leu.2404334 · Cited by 125

Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

Saad, A. A., Lima, M. J. G. D., Anand, S. M., Bhatt, V. R., Bookout, R., Chen, G. L., Couriel, D. R., Stasi, A. D., El-Jawahri, A. R., Giralt, S., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.0021 · Cited by 126

Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM–comorbidity score

Kleber, M., Ihorst, G., Terhorst, M., Koch, B., Deschler-Baier, B., Wäsch, R., & Engelhardt, M. M. (2011) · Blood Cancer Journal · doi:10.1038/bcj.2011.34 · Cited by 123

Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma

Saad, A. A., Mahindra, A. K., Zhang, M., Zhong, X., Costa, L. J., Dispenzieri, A. A., Drobyski, W. R., Freytes, C. O., Gale, R. P., Gasparetto, C., et al. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.12.557 · Cited by 122

The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission

Huang, X., Zhu, H., Chang, Y., Xu, L., Liu, D., Zhang, X., Jiang, B., Jiang, Q., Jiang, H., Chen, Y., et al. (2012) · Blood · doi:10.1182/blood-2011-11-389809 · Cited by 120

Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors

Peccatori, J., Forcina, A., Clerici, D. T., Crocchiolo, R., Vago, L., Stanghellini, M. T. L., Noviello, M., Messina, C., Crotta, A., Assanelli, A. A., et al. (2014) · Leukemia · doi:10.1038/leu.2014.180 · Cited by 120

Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil

Moiseev, I., Pirogova, O. V., Alyanski, A. L., Babenko, E. V., Gindina, T., Darskaya, E. I., Slesarchuk, O. A., Bondarenko, S. N., & Afanasyev, B. V. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.03.004 · Cited by 119

Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation

Bergeron, A., Chevret, S., de Latour, R. P., Chagnon, K., de Margerie‐Mellon, C., Rivière, F., Robin, M., Mani, J., Lorillon, G., Socié, G., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.02617-2017 · Cited by 118

The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience

Loke, J. C. T., Malladi, R. K., Moss, P. A. H., & Craddock, C. (2019) · British Journal of Haematology · doi:10.1111/bjh.16355 · Cited by 122

Three decades of transplantation for chronic myeloid leukemia: what have we learned?

Pavlů, J., Szydlo, R., Goldman, J. M., & Apperley, J. F. (2010) · Blood · doi:10.1182/blood-2010-08-301341 · Cited by 117

Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD

Bejanyan, N., Brunstein, C. G., Cao, Q., Lazaryan, A., Luo, X., Curtsinger, J., Mehta, R. S., Warlick, E. D., Cooley, S., Blazar, B. R., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017014464 · Cited by 117

Reduced-Intensity Allogeneic Transplant in Patients Older Than 55 Years: Unrelated Umbilical Cord Blood Is Safe and Effective for Patients without a Matched Related Donor

Majhail, N. S., Brunstein, C. G., Tomblyn, M., Thomas, A. J., Miller, J. S., Arora, M., Kaufman, D. S., Burns, L. J., Slungaard, A., McGlave, P. B., et al. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.12.488 · Cited by 117

Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials

Goede, V., Cramer, P., Busch, R., Bergmann, M., Stauch, M. B., Hopfinger, G., Stilgenbauer, S., Döhner, H., Westermann, A., Wendtner, C., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.096792 · Cited by 116

Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group

Sperr, W. R., Wimazal, F., Kundi, M., Baumgärtner, C., Nösslinger, T., Makrai, A., Stauder, R., Krieger, O., Pfeilstöcker, M., & Valent, P. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp258 · Cited by 116

Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide Therapy vs Other Donor Transplantations in Adults With Hematologic Cancers

Gagelmann, N., Bacigalupo, A. P., Rambaldi, A., Hoelzer, D. F., Halter, J. P., Sanz, J., Bonifazi, F., Meijer, E., Itälä‐Remes, M., Marková, M., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.3541 · Cited by 114

Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study

Raimondi, R., Tosetto, A., Oneto, R., Cavazzina, R., Rodeghiero, F., Bacigalupo, A. P., Fanin, R., Rambaldi, A., & Bosi, A. (2012) · Blood · doi:10.1182/blood-2012-03-414573 · Cited by 114

Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors

Shaffer, B. C., Gooptu, M., DeFor, T. E., Maiers, M. J., Bolaños‐Meade, J., Abboud, R., Briggs, A. D., Khimani, F., Modi, D., Newcomb, R. A., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.24.00184 · Cited by 111

Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC)

Robin, M., Tabrizi, R., Mohty, M., Fürst, S., Michallet, M., Bay, J., Cahn, J.-Y. Y., Coninck, E. D., Dhédin, N., Bernard, M., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08417.x · Cited by 111

The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation

Farina, L., Bruno, B., Patriarca, F. F., Spina, F., Sorasio, R., Morelli, M., Fanin, R., Boccadoro, M., & Corradini, P. (2009) · Leukemia · doi:10.1038/leu.2009.1 · Cited by 111

Guideline for the diagnosis and management of myelofibrosis

Reilly, J. T., McMullin, M. F., Beer, P. A., Butt, N. M., Conneally, E., Duncombe, A. S., Green, A. R., Mikhaeel, N. G., Gilleece, M. H., Hall, G. W., et al. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09179.x · Cited by 111

Management of Acute Myeloid Leukemia: A Review for General Practitioners in Oncology

Stubbins, R. J., Francis, A., Kuchenbauer, F. C., & Sanford, D. (2022) · Current Oncology · doi:10.3390/curroncol29090491 · Cited by 109

Who is fit for allogeneic transplantation?

Deeg, H. J., & Sandmaier, B. M. (2010) · Blood · doi:10.1182/blood-2010-07-259358 · Cited by 111

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

Mielcarek, M. B., Furlong, T., Storer, B. E., Green, M. L., McDonald, G., Carpenter, P. A., Flowers, M. E. D., Storb, R. F., Boeckh, M., & Martin, P. J. (2015) · Haematologica · doi:10.3324/haematol.2014.118471 · Cited by 109

Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force

Stauder, R., Eichhorst, B. F., Hamaker, M. E., Kaplanov, K. D., Morrison, V. A., Österborg, A., Poddubnaya, I. V., Woyach, J. A., Shanafelt, T. D., Smolej, L., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw547 · Cited by 109

Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide

Dezern, A. E., Franklin, C., Tsai, H., Imus, P. H., Cooke, K. R., Varadhan, R., & Jones, R. J. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003922 · Cited by 106

Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT

Fuji, S., Takano, K., Mori, T., Eto, T., Taniguchi, S., Ohashi, K., Sakamaki, H., MORISHIMA, Y., Kato, K., Miyamura, K., et al. (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.178 · Cited by 107

Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation

Bachanová, V., Verneris, M. R., DeFor, T. E., Brunstein, C. G., & Weisdorf, D. J. (2009) · Blood · doi:10.1182/blood-2008-10-184093 · Cited by 106

Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies

Braamse, A. M. J., Gerrits, M. M. J. G., van Meijel, B., Visser, O., van Oppen, P., Boenink, A. D., Cuijpers, P., Huijgens, P. C., Beekman, A. T. F., & Dekker, J. (2012) · Bone Marrow Transplantation · doi:10.1038/bmt.2011.130 · Cited by 101

Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT

Fitzhugh, C. D., Hsieh, M. M., Taylor, T. N., Coles, W. A., Roskom, K., Wilson, D., Wright, E. C., Jeffries, N. O., Gamper, C. J., Powell, J. D., et al. (2017) · Blood Advances · doi:10.1182/bloodadvances.2016002972 · Cited by 104

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?

Loke, J. C. T., Buka, R. J., & Craddock, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.659595 · Cited by 119

Real-world experience of CAR T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma

Chihara, D., Liao, L., Tkacz, J. P., Franco, A., Lewing, B., Kilgore, K. M., Nastoupil, L. J., & Chen, L. (2023) · Blood · doi:10.1182/blood.2023020197 · Cited by 105

Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial

Houot, R., Bachy, E., Cartron, G., Gros, F., Morschhauser, F., Obéric, L., Gastinne, T., Feugier, P., Duléry, R., Thiéblemont, C., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02572-5 · Cited by 105

Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization

Pidala, J., Kim, J., Schell, M. J., Lee, S. J., Hillgruber, R., Nye, V., Ayala, E., Alsina, M., Betts, B. C., Bookout, R., et al. (2012) · Bone Marrow Transplantation · doi:10.1038/bmt.2012.150 · Cited by 105

Donor and recipient sex in allogeneic stem cell transplantation: what really matters

Kim, H. T., Zhang, M.-J., Woolfrey, A. E., Martin, A. S., Chen, J., Saber, W., Perales, M., Armand, P. A., & Eapen, M. (2016) · Haematologica · doi:10.3324/haematol.2016.147645 · Cited by 104

Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting

Rotta, M., Storer, B. E., Sahebi, F., Shizuru, J. A., Bruno, B., Lange, T., Agura, E. D., McSweeney, P. A., Pulsipher, M. A., Hari, P., et al. (2008) · Blood · doi:10.1182/blood-2008-07-170746 · Cited by 103

Factors Associated With Outcomes in Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning After Failed Myeloablative Hematopoietic Cell Transplantation

Baron, F., Storb, R. F., Storer, B. E., Maris, M. B., Niederwieser, D. W., Shizuru, J. A., Chauncey, T. R., Bruno, B., Forman, S. J., McSweeney, P. A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.9914 · Cited by 104

Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS)

Saber, W., Cutler, C. S., Nakamura, R., Zhang, M., Atallah, E. L., Rizzo, J. D., Maziarz, R. T., Cortes, J. E., Kalaycio, M. E., & Horowitz, M. M. (2013) · Blood · doi:10.1182/blood-2013-04-496778 · Cited by 104

Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome

Brown, J. R., Kim, H. T., Armand, P. A., Cutler, C. S., Fisher, D. C., Ho, V. T., Koreth, J., Ritz, J., Wu, C. J., Antin, J. H., et al. (2012) · Leukemia · doi:10.1038/leu.2012.228 · Cited by 103

High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies

Dreger, P., Ghia, P., Schetelig, J., van Gelder, M., Kimby, E. K., Michallet, M., Moreno, C., Robak, T., Stilgenbauer, S., & Montserrat, E. (2018) · Blood · doi:10.1182/blood-2018-01-826008 · Cited by 105

Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia

Matthews, A. H., Perl, A. E., Luger, S. M., Loren, A. W., Gill, S. I., Porter, D. L., Babushok, D. V., Maillard, I. P., Carroll, M. P., Frey, N. V., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007265 · Cited by 104

Systematic Nutritional Support in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Fuji, S., Einsele, H., Savani, B. N., & Kapp, M. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.07.003 · Cited by 108

Clinical and genetic predictors of prognosis in myelodysplastic syndromes

Bejar, R. L. (2014) · Haematologica · doi:10.3324/haematol.2013.085217 · Cited by 107

Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide

on behalf of the Japan Study Group for Cell Therapy and Transplantation (JSCT), Sugita, J., Kagaya, Y., Miyamoto, T., Shibasaki, Y., Nagafuji, K., Ota, S., Furukawa, T., Nara, M., Akashi, K., et al. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-018-0279-1 · Cited by 102

Conditioning with Treosulfan and Fludarabine followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Nemecek, E. R., Guthrie, K. A., Sorror, M. L., Wood, B. L., Doney, K., Hilger, R. A., Scott, B. L., Kovacsovics, T. J., Maziarz, R. T., Woolfrey, A. E., et al. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.05.007 · Cited by 101

External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation

Shouval, R., Fein, J. A., Shouval, A., Danylesko, I., Shem‐Tov, N., Zlotnik, M., Yerushalmi, R., Shimoni, A., & Nagler, A. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019032268 · Cited by 102

Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis

Versluis, J., Hazenberg, C. L. E., Passweg, J. R., van Putten, W. L. J., Maertens, J. A., Biemond, B. J., Theobald, M., Graux, C., Kuball, J. H. E., Schouten, H. C., et al. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00148-9 · Cited by 100

Current challenges and unmet medical needs in myelodysplastic syndromes

Platzbecker, U., Kubasch, A. S., Homer-Bouthiette, C., & Prébet, T. (2021) · Leukemia · doi:10.1038/s41375-021-01265-7 · Cited by 103

Non‐myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B‐cell lymphoma: a multicentre experience

Rezvani, A. R., Norasetthada, L., Gooley, T. A., Sorror, M. L., Bouvier, M. E., Sahebi, F., Agura, E. D., Chauncey, T. R., Maziarz, R. T., Maris, M. B., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07365.x · Cited by 100

Performance Status in Cancer: Not Broken, But Time for an Upgrade?

Scott, J. M., Stene, G. B., Edvardsen, E., & Jones, L. W. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00721 · Cited by 101

Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis

Üstün, C., Gotlib, J. R., Popat, U., Artz, A. S., Litzow, M. R., Reiter, A., Nakamura, R., Kluin‐Nelemans, H. C., Verstovšek, S., Gajewski, J., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.04.018 · Cited by 103

A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation

Pidala, J., Kim, J., Jim, H., Kharfan‐Dabaja, M. A., Nishihori, T., Fernandez, H. F., Tomblyn, M. R., Perez, L. E., Perkins, J. B., Xu, M., et al. (2012) · Haematologica · doi:10.3324/haematol.2012.067140 · Cited by 98

Geriatric assessment in older patients with acute myeloid leukemia: A retrospective study of associated treatment and outcomes

Sherman, A. E., Motyckova, G., Fega, K. R., DeAngelo, D. J., Abel, G. A., Steensma, D. P., Wadleigh, M., Stone, R. M., & Driver, J. A. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.05.013 · Cited by 98

Effect of Intensive Chemotherapy on Physical, Cognitive, and Emotional Health of Older Adults with Acute Myeloid Leukemia

Klepin, H. D., Tooze, J. A., Pardee, T. S., Ellis, L. R., Berenzon, D. P., Mihalko, S. L., Danhauer, S. C., Rao, A. V., Wildes, T. M., Williamson, J. D., et al. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14301 · Cited by 98

Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

Ciurea, S. O., Shah, M. V., Saliba, R. M., Gaballa, S. R., Kongtim, P., Rondón, G., Chen, J. J., Wallis, W. D., Cao, K., Konopleva, M. Y., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.09.005 · Cited by 98

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group

Pleyer, L., Burgstaller, S., Girschikofsky, M., Linkesch, W., Stauder, R., Pfeilstöcker, M., Schreder, M., Tinchon, C., Sliwa, T., Lang, A. H., et al. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2126-9 · Cited by 97

Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide

McCurdy, S. R., Zhang, M., Martin, A. S., Malki, M. M. A., Bashey, A., Gaballa, S. R., Keesler, D. A., Hamadani, M., Norkin, M., Perales, M., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017014829 · Cited by 97

Effects of physical exercise on survival after allogeneic stem cell transplantation

Wiskemann, J., Kleindienst, N., Kuehl, R., Dreger, P., Schwerdtfeger, R., & Bohus, M. (2015) · International Journal of Cancer · doi:10.1002/ijc.29633 · Cited by 96

Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality

Fuji, S., Mori, T., Khattry, N., Cheng, J. H., R, Y., Yakushijin, K., Kohashi, S., Fukuda, T., Kim, S.-W., & on behalf of the Nutritional Support Working Group of the Asian Pacific Bone Marrow Transplantation (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.228 · Cited by 96

Guidelines for the diagnosis and management of adult myelodysplastic syndromes

Killick, S. B., Carter, C., Culligan, D. J., Dalley, C. D., Das-Gupta, E. P., Drummond, M. W., Enright, H., Jones, G. L., Kell, J., Mills, J., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12694 · Cited by 97

Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission

Walter, R. B., Pagel, J. M., Gooley, T. A., Petersdorf, E. W., Sorror, M. L., Woolfrey, A. E., Hansen, J. A., Salter, A. I., Lansverk, E., Stewart, F. M., et al. (2010) · Leukemia · doi:10.1038/leu.2010.102 · Cited by 99

The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome

Zipperer, E., Pelz, D., Nachtkamp, K., Kuendgen, A., Strupp, C., Gattermann, N., Haas, R. R., & Germing, U. (2009) · Haematologica · doi:10.3324/haematol.2008.002063 · Cited by 95

Non-HLA immunogenetics in hematopoietic stem cell transplantation

Dickinson, A. M., & Charron, D. J. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.07.017 · Cited by 93

Autologous stem cell transplantation in elderly patients (>=60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry

Jantunen, E., Canals, C., Rambaldi, A., Ossenkoppele, G. J., Allione, B., Blaise, D., Condé, E., Tilly, H., Cook, G., Clark, F. J., et al. (2008) · Haematologica · doi:10.3324/haematol.13273 · Cited by 93

Comorbidities, Not Age, Impact Outcomes in Autologous Stem Cell Transplant for Relapsed Non-Hodgkin Lymphoma

Wildes, T. M., Augustin, K. M., Sempek, D. S., Zhang, Q. J., Vij, R., DiPersio, J. F., & Devine, S. M. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.05.002 · Cited by 92

Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology

Rassaf, T., Totzeck, M., Backs, J., Bokemeyer, C., Hallek, M. J., Hilfiker‐Kleiner, D., Hochhaus, A., Lüftner, D., Müller, O. J., Neudorf, U., et al. (2020) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01636-7 · Cited by 97

Dose intensity for conditioning in allogeneic hematopoietic cell transplantation: can we recommend “when and for whom” in 2021?

Gagelmann, N., & Kröger, N. M. (2021) · Haematologica · doi:10.3324/haematol.2020.268839 · Cited by 92

Building the graph of medicine from millions of clinical narratives

Finlayson, S. G., LePendu, P., & Shah, N. H. (2014) · Scientific Data · doi:10.1038/sdata.2014.32 · Cited by 94

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult

Morris, E. C., Fox, T. A., Chakraverty, R. K., Rego, R. T., Snell, K., Rivat, C., Grace, S., Gilmour, K. C., Workman, S., Buckland, K. F., et al. (2017) · Blood · doi:10.1182/blood-2017-04-777136 · Cited by 93

TRANSPLANTATION Hematopoietic cell transplantation (HCT)–specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Sorror, M. L., Maris, M. B., Storb, R. F., Baron, F., S, B. M., Maloney, D. G., & Storer, B. E. (2016)

Assignment of scores for the hematopoietic cell transplantation comorbidity index: integer vs exact weights

Sorror, M. L., Storer, B. E., & Storb, R. F. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.131 · Cited by 9

54: Hematopoietic cell transplantation-comorbidity index (HCT-CI)

Kassar, M., Shell, K., Gregory, S. A., Venugopal, P., Shammo, J. M., & Fung, H. C. H. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.12.057

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Kato, R., Fukuda, T., Usui, E., Yamasaki, S., Maruyama, D., Morita, Y., Kim, S., Mori, S., Tanosaki, R., Tajima, K., et al. (2005) · Blood · doi:10.1182/blood.v106.11.2731.2731 · Cited by 1

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study

Sorror, M. L., Logan, B. R., Zhu, X., Rizzo, J. D., Cooke, K. R., McCarthy, P. L., Ho, V. T., Horowitz, M. M., & Pasquini, M. C. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.04.004 · Cited by 222